The most frequently and thoroughly studied type of hematological toxicity in vitro is the acute effect of the toxicant on myeloid progenitor cells such as granulocyte-macrophages. Creative Biolabs supports myeloid progenitor assays by Colony-Forming Unit-Granulocyte/Macrophage (CFU-GM) to study the hematotoxicity of drugs and chemicals on the myeloid cell compartment.
Neutrophils are short-lived, circulating white blood cells that provide a critical line of defense against microbial infections. Neutrophils are continuously produced by rapidly proliferating precursor cells in hematopoietic tissues called colony-forming units-granulocyte/macrophage (CFU-GM), so named because they form clonal colonies in semisolid cell cultures when stimulated with appropriate cytokines. These special cell types produce new replacement neutrophils, and, when they fall to abnormally low levels in the blood, the risk of infection increases.
Preparation of Human Hematopoietic Progenitor Cells(Which are isolated from fresh or frozen human cord blood.)
|
Preparation of Murine Hematopoietic Progenitors (m-BM) Cells
|
Prepare Methylcellulose Culture Medium (MCM) Stocks | |
Perform CFU-GM Assay | |
Identify and Count the Colonies
· Count the colonies after 7 days (murine model) or 14 days (human model) of CFC-Assay |
|
Interpretation of Results from CFU-GM Assay |
Creative Biolabs possesses professional myeloid progenitor assay methods and processes to assist you in your drug development research. With professional model building knowledge and excellent service team, Creative Biolabs promises to provide high quality experimental modes which cover a variety of types at cell, organ, and tissue levels to meet all your research needs. The models we can provide include but are not limited to:
Please contact us to let us know what you need.